e-learning
resources
Munich 2014
Tuesday, 09.09.2014
ILDs 6
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Amphetamine induced eosinophilic pneumonia: A case report
K. Rososinska, S. Henschke, M. Reichert, R. Bals (Homburg/Saar, Germany)
Source:
International Congress 2014 – ILDs 6
Session:
ILDs 6
Session type:
Thematic Poster Session
Number:
3795
Abstract
Idiopathic acute eosinophilic pneumonia is a rare disease. It presents with acute febrile illness, respiratory insufficiency, pulmonary infiltration and high eosinophil levels in broncho alveolar lavage fluid. Its pathogenesis is not well understood, but may relate to the exposure to exogenous substances (e.g. cocaine or heroin).A 25 year old female presented to our emergency department with a chief complaint of dyspnea and cough starting two weeks ago. Despite the application of several antibiotics her complaints worsened.Her examination at the time of presentation revealed an oxygen saturation at room air of 88%, and a chest x-ray with bilateral infiltrates. Laboratory analysies demonstrated the following observations: Eosinophil blood count was 37.2% and the sputum eosinophil count was 36.0%.A preliminary diagnosis of eosinophilic pneumonia was made. High-dose steroids (prednisolone 40mg/d) and antibiotic treatment (clarithromycin) was promptly started. There was immediate improvement, oxygen insufflation was reduced and laboratory results returned to normal level (eosinophils in blood 2% and in sputum 3%).An amphetamine drug test in urine was positive. No increase of ANA, pANCA, cANCA or rheumatoid factors were detected.After 4 weeks, complete resolution of symptoms and radiographical abnormalities were noted. Her respiratory function parameters were initially FEV1 1.99 l (64% S) and VC 2.57 l (71% S) and after treatment FEV1 2.92 l (93% S) and VC 3.73 l (103% S).This is the second case report (Whithaus KC and Rutland BM, 2008) suggesting that amphetamine intake might induce the development of lung infiltrates with accompanying peripheral blood eosinophilia and high eosinophil level in sputum.
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Rososinska, S. Henschke, M. Reichert, R. Bals (Homburg/Saar, Germany). Amphetamine induced eosinophilic pneumonia: A case report. Eur Respir J 2014; 44: Suppl. 58, 3795
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Clinical analysis of 32 cases of biopsy-proven secondary organizing pneumonia following community-acquired pneumonia
Source: International Congress 2014 – ILDs 4
Year: 2014
Morality predictors in acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 6
Year: 2014
Homooligomerization of the ABC-transporter 3 and its functional significance
Source: International Congress 2014 – ILDs 3
Year: 2014
Management of spontaneous pneumothorax in patients with or without Birt-Hogg-Dubé syndrome
Source: International Congress 2014 – ILDs 1
Year: 2014
Outcome of acute drug-induced pneumonias in ICU
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Acute exacerbation of idiopathic pulmonary fibrosis: Analysis in a post-marketing surveillance of pirfenidone
Source: International Congress 2014 – Clinical trials in IPF
Year: 2014
Pulmonary manifestations in severe strongyloidiasis: Review of 17 cases
Source: International Congress 2015 – A morphological view of chest pathology
Year: 2015
Prognostic significance of asymmetrical distribution of opacities on high-resolution computed tomography in acute exacerbation of interstitial pneumonia
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Serum procalcitonin is useful in differentiating between drug-induced pneumonitis and bacterial pneumonia
Source: International Congress 2014 – ILDs 5
Year: 2014
Recent improvement of survival of acute exacerbation in idiopathic interstitial pneumonias: 10 years experience
Source: International Congress 2014 – ILDs 2
Year: 2014
Airway centered interstitial fibrosis – An under-recognized type of idiopathic interstitial pneumonia
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
Desquamative interstitial pneumonia in a Danish cohort, treatment response and outcome
Source: International Congress 2014 – ILDs 2
Year: 2014
Does hypoxemia increases risks in hospitalized patients with diffuse interstitial lung disease?
Source: International Congress 2014 – ILDs 6
Year: 2014
Clinical features of four children with pulmonary alveolar proteinosis
Source: International Congress 2014 – ILDs 5
Year: 2014
Description of a murine model of acute pneumonitis hypersensitivity to pigeon serum
Source: International Congress 2014 – ILDs 2
Year: 2014
Aetiological panorama in the diagnosis of interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014
Diagnosis of cardiac sarcoidosis: A crossectional study in 327 consecutive patients
Source: International Congress 2014 – Sarcoidosis
Year: 2014
6MWT performance by means of Spiropalm in patients affected by fibrotic idiopathic interstitial pneumonias: Preliminary observations
Source: International Congress 2014 – ILDs 6
Year: 2014
LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Acute fibrinous and organizing pneumonia: A retrospective study
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept